BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ganini C, Amelio I, Bertolo R, Bove P, Buonomo OC, Candi E, Cipriani C, Di Daniele N, Juhl H, Mauriello A, Marani C, Marshall J, Melino S, Marchetti P, Montanaro M, Natale ME, Novelli F, Palmieri G, Piacentini M, Rendina EA, Roselli M, Sica G, Tesauro M, Rovella V, Tisone G, Shi Y, Wang Y, Melino G. Global mapping of cancers: The Cancer Genome Atlas and beyond. Mol Oncol 2021. [PMID: 34245122 DOI: 10.1002/1878-0261.13056] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 18.0] [Reference Citation Analysis]
Number Citing Articles
1 Wang X, Huang H, Liu X, Li J, Wang L, Li L, Li Y, Han T. Immunogenic cell death-related classifications in breast cancer identify precise immunotherapy biomarkers and enable prognostic stratification. Front Genet 2022;13. [DOI: 10.3389/fgene.2022.1052720] [Reference Citation Analysis]
2 Liu Z, Xu H, Liu L, Weng S, Xing Z, Ren Y, Ge X, Wang L, Guo C, Chen S, Cheng Q, Luo P, Zhang J, Han X. SurvivalML: an integrative platform for the discovery and exploration of prognostic models in multi-center cancer cohorts.. [DOI: 10.1101/2022.10.25.513678] [Reference Citation Analysis]
3 Xu Y, Zou X, Mei J, Gu Y. The Risk Correlation between N7-Methylguanosine Modification-Related lncRNAs and Survival Prognosis of Oral Squamous Cell Carcinoma Based on Comprehensive Bioinformatics Analysis. Applied Bionics and Biomechanics 2022;2022:1-11. [DOI: 10.1155/2022/1666792] [Reference Citation Analysis]
4 Wu J, Li N, Zhu L, Zhen D, Li M, Chen H, Ye M, Wei Y, Shao G. Multiple roles of apolipoprotein B mRNA editing enzyme catalytic subunit 3B (APOBEC3B) in human tumors: a pan-cancer analysis. BMC Bioinformatics 2022;23:312. [PMID: 35918642 DOI: 10.1186/s12859-022-04862-0] [Reference Citation Analysis]
5 Nevedomskaya E, Haendler B. From Omics to Multi-Omics Approaches for In-Depth Analysis of the Molecular Mechanisms of Prostate Cancer. Int J Mol Sci 2022;23:6281. [PMID: 35682963 DOI: 10.3390/ijms23116281] [Reference Citation Analysis]
6 Ganini C, Montanaro M, Scimeca M, Palmieri G, Anemona L, Concetti L, Melino G, Bove P, Amelio I, Candi E, Mauriello A. No Time to Die: How Kidney Cancer Evades Cell Death. IJMS 2022;23:6198. [DOI: 10.3390/ijms23116198] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Ou D, Zhang Z, Wu Z, Shen P, Huang Y, She S, She S, Lin M. Identification of the Putative Tumor Suppressor Characteristics of FAM107A via Pan-Cancer Analysis. Front Oncol 2022;12:861281. [DOI: 10.3389/fonc.2022.861281] [Reference Citation Analysis]
8 Liu S, Suhail Y, Novin A, Perpetua L, Kshitiz. Metastatic Transition of Pancreatic Ductal Cell Adenocarcinoma Is Accompanied by the Emergence of Pro-Invasive Cancer-Associated Fibroblasts. Cancers (Basel) 2022;14:2197. [PMID: 35565326 DOI: 10.3390/cancers14092197] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Degasperi A, Zou X, Dias Amarante T, Martinez-martinez A, Koh GCC, Dias JML, Heskin L, Chmelova L, Rinaldi G, Wang VYW, Nanda AS, Bernstein A, Momen SE, Young J, Perez-gil D, Memari Y, Badja C, Shooter S, Czarnecki J, Brown MA, Davies HR, Nik-zainal S, Ambrose JC, Arumugam P, Bevers R, Bleda M, Boardman-pretty F, Boustred CR, Brittain H, Caulfield MJ, Chan GC, Fowler T, Giess A, Hamblin A, Henderson S, Hubbard TJP, Jackson R, Jones LJ, Kasperaviciute D, Kayikci M, Kousathanas A, Lahnstein L, Leigh SEA, Leong IUS, Lopez FJ, Maleady-crowe F, Mcentagart M, Minneci F, Moutsianas L, Mueller M, Murugaesu N, Need AC, O‘donovan P, Odhams CA, Patch C, Perez-gil D, Pereira MB, Pullinger J, Rahim T, Rendon A, Rogers T, Savage K, Sawant K, Scott RH, Siddiq A, Sieghart A, Smith SC, Sosinsky A, Stuckey A, Tanguy M, Taylor Tavares AL, Thomas ERA, Thompson SR, Tucci A, Welland MJ, Williams E, Witkowska K, Wood SM; Genomics England Research Consortium†. Substitution mutational signatures in whole-genome–sequenced cancers in the UK population. Science 2022;376:abl9283. [DOI: 10.1126/science.abl9283] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 15.0] [Reference Citation Analysis]
10 Barchi JJ Jr. Glycoconjugate Nanoparticle-Based Systems in Cancer Immunotherapy: Novel Designs and Recent Updates. Front Immunol 2022;13:852147. [PMID: 35432351 DOI: 10.3389/fimmu.2022.852147] [Reference Citation Analysis]
11 Wan F, Chen F, Fan Y, Chen D. Clinical Significance of TET2 in Female Cancers. Front Bioeng Biotechnol 2022;10:790605. [DOI: 10.3389/fbioe.2022.790605] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 Zhang H, He C, Guo X, Fang Y, Lai Q, Wang X, Pan X, Li H, Qin K, Li A, Liu S, Li Q. DDX39B contributes to the proliferation of colorectal cancer through direct binding to CDK6/CCND1. Cell Death Discov 2022;8. [DOI: 10.1038/s41420-022-00827-7] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
13 Lee KJ, Betz-stablein B, Stark MS, Janda M, Mcinerney-leo AM, Caffery LJ, Gillespie N, Yanes T, Soyer HP. The Future of Precision Prevention for Advanced Melanoma. Front Med 2022;8:818096. [DOI: 10.3389/fmed.2021.818096] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
14 García-Padilla C, Dueñas Á, García-López V, Aránega A, Franco D, Garcia-Martínez V, López-Sánchez C. Molecular Mechanisms of lncRNAs in the Dependent Regulation of Cancer and Their Potential Therapeutic Use. Int J Mol Sci 2022;23:764. [PMID: 35054945 DOI: 10.3390/ijms23020764] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
15 Sawhney A, Imran M, Zulfiquar S, Tauseef M. Careers and Opportunities in Medical Biotechnology. Fundamentals and Advances in Medical Biotechnology 2022. [DOI: 10.1007/978-3-030-98554-7_15] [Reference Citation Analysis]
16 Nelakurti DD, Rossetti T, Husbands AY, Petreaca RC. Arginine Depletion in Human Cancers. Cancers (Basel) 2021;13:6274. [PMID: 34944895 DOI: 10.3390/cancers13246274] [Reference Citation Analysis]
17 Rozenberg JM, Zvereva S, Dalina A, Blatov I, Zubarev I, Luppov D, Bessmertnyi A, Romanishin A, Alsoulaiman L, Kumeiko V, Kagansky A, Melino G, Barlev NA. Dual Role of p73 in Cancer Microenvironment and DNA Damage Response. Cells 2021;10:3516. [PMID: 34944027 DOI: 10.3390/cells10123516] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
18 Rozenberg JM, Zvereva S, Dalina A, Blatov I, Zubarev I, Luppov D, Bessmertnyi A, Romanishin A, Alsoulaiman L, Kumeiko V, Kagansky A, Melino G, Ganini C, Barlev NA. The p53 family member p73 in the regulation of cell stress response. Biol Direct 2021;16:23. [PMID: 34749806 DOI: 10.1186/s13062-021-00307-5] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 10.0] [Reference Citation Analysis]
19 Ji LY, Wei M, Liu YY, Di ZL, Li SZ. miR‑497/MIR497HG inhibits glioma cell proliferation by targeting CCNE1 and the miR‑588/TUSC1 axis. Oncol Rep 2021;46:255. [PMID: 34664678 DOI: 10.3892/or.2021.8206] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]